279 related articles for article (PubMed ID: 16620147)
21. Ranolazine in patients with angina and coronary artery disease.
Scirica BM; Morrow DA
Curr Cardiol Rep; 2007 Jul; 9(4):272-8. PubMed ID: 17601393
[TBL] [Abstract][Full Text] [Related]
22. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
23. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
24. Ranolazine for chronic stable angina.
Nash DT; Nash SD
Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
26. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
27. Ranolazine (Ranexa) for chronic stable angina.
Ndegwa S
Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
[TBL] [Abstract][Full Text] [Related]
28. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
29. Ranolazine: a new approach to management of patients with angina.
Tafreshi MJ; Fisher E
Ann Pharmacother; 2006 Apr; 40(4):689-93. PubMed ID: 16595572
[TBL] [Abstract][Full Text] [Related]
30. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
[TBL] [Abstract][Full Text] [Related]
31. [Ranolazine--an additional anti-anginal drug].
Michels G; Kochanek M; Hoppe UC
Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
[TBL] [Abstract][Full Text] [Related]
32. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
33. Ranolazine, a novel agent for chronic stable angina.
Gaffney SM
Pharmacotherapy; 2006 Jan; 26(1):135-42. PubMed ID: 16506355
[TBL] [Abstract][Full Text] [Related]
34. Extended-release ranolazine: critical evaluation of its use in stable angina.
Truffa AA; Newby LK; Melloni C
Vasc Health Risk Manag; 2011; 7():535-9. PubMed ID: 21915171
[TBL] [Abstract][Full Text] [Related]
35. Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders.
Bhandari B; Subramanian L
Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):35-9. PubMed ID: 18221101
[TBL] [Abstract][Full Text] [Related]
36. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.
Hidalgo-Vega A; Ramos-Goñi JM; Villoro R
Eur J Health Econ; 2014 Dec; 15(9):917-25. PubMed ID: 24122303
[TBL] [Abstract][Full Text] [Related]
37. Ranolazine: new drug. Stable angina: not worth the risk.
Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacokinetics of ranolazine.
Jerling M
Clin Pharmacokinet; 2006; 45(5):469-91. PubMed ID: 16640453
[TBL] [Abstract][Full Text] [Related]
39. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
Wenger NK; Chaitman B; Vetrovec GW
Am J Cardiol; 2007 Jan; 99(1):11-8. PubMed ID: 17196454
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
